Chemomab Therapeutics Ltd. ADR Company Profile
NASDAQ: CMMBHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Chemomab Therapeutics at a glance
Chemomab Therapeutics Ltd. ADR (NASDAQ: CMMB) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in Tel Aviv-Yafo, Israel. Chemomab Therapeutics is led by Dr. Adi Mor George Ph.D.. The company's shares have traded publicly since 2019.
At a market capitalization of $10.2 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001534248, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does Chemomab Therapeutics do?
Chemomab Therapeutics Ltd., a clinical-stage biotechnology company, focuses on the discovery and development of therapeutics for the treatment of fibrotic and inflammatory diseases. Its lead product candidate is nebokitug, a humanized monoclonal antibody that attenuates the basic function of CCL24 as a regulator of major inflammatory and fibrotic pathways, which has completed phase 2 clinical trial for treating primary sclerosing cholangitis, as well as in phase 2 clinical trial to treat systemic sclerosis. The company was founded in 2011 and is based in Tel Aviv-Yafo, Israel.
Business description based on the company's public filings.
Company information
- Legal name
- Chemomab Therapeutics Ltd. ADR
- Ticker
- NASDAQ: CMMB
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- CEO
- Dr. Adi Mor George Ph.D.
- Headquarters
- Building C, Tel Aviv-Yafo, Israel
- Phone
- 972 77 331 0156
- Website
- chemomab.com
- IPO year
- 2019
- Market cap
- $10.19M
- SEC CIK
- 0001534248
Companies similar to Chemomab Therapeutics
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| TOVXTheriva Biologics Inc. | 0.2271 | -2.95% | $10.42M | vs CMMB |
| ADILAdial Pharmaceuticals Inc | 3.97 | -0.50% | $10.42M | vs CMMB |
| GTBPGT Biopharma Inc. | 5.96 | -3.87% | $10.75M | vs CMMB |
| VTGNVistagen Therapeutics Inc. | 0.2462 | -0.36% | $10.93M | vs CMMB |
| BLRXBioLineRx Ltd. ADR | 2.21 | +0.23% | $11.00M | vs CMMB |
| BIVIBioVie Inc. Class A | 1.28 | -8.57% | $11.11M | vs CMMB |
| KPRXKiora Pharmaceuticals Inc. | 2.53 | 0.00% | $11.19M | vs CMMB |
| GDTCCytoMed Therapeutics Limited | 0.9449 | -3.56% | $11.28M | vs CMMB |